If the researchers have a suspicion that the new intervention is working far better than the control (trial being extended), don't they have a moral obligation to shut the trial down now and give the patients on the control drug the opportunity to have the new intervention? Does anyone know?
- Forums
- ASX - By Stock
- primary completion date ph. 3 trial
If the researchers have a suspicion that the new intervention is...
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable